FDA to conduct workshop on risk minimization programs
How should risk minimization programs be designed to promote better health care? That's the focus of an upcoming two-day workshop to be held by the FDA.
How should risk minimization programs be designed to promote better health care? That's the focus of an upcoming two-day workshop to be held by the FDA. The agency said it is particularly interested in looking at reminder systems that prompt health professionals and patients about the prescribing, dispensing, or use of products in ways that minimize risk. The workshop will be held June 25-26 at the AHRQ office in Rockville, Md. Comments to FDA should be submitted by July 31. For more information about the event, click
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
